Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-08-02
2005-08-02
Weber, Jon (Department: 1653)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S069100, C435S320100, C435S325000, C530S350000, C530S381000
Reexamination Certificate
active
06924365
ABSTRACT:
The present invention is directed to a synthetic nucleic acid sequence which encodes a protein wherein at least one non-common codon or less-common codon is replaced by a common codon. The synthetic nucleic acid sequence can include a continuous stretch of at least 90 codons all of which are common codons.
REFERENCES:
patent: 4965199 (1990-10-01), Capon et al.
patent: 5786464 (1998-07-01), Seed
patent: 5795737 (1998-08-01), Seed et al.
patent: 6034072 (2000-03-01), Ralston et al.
patent: 96/09378 (1996-03-01), None
patent: WO 96/09378 (1996-03-01), None
patent: WO 97/11086 (1997-03-01), None
patent: WO 97/26333 (1997-07-01), None
patent: WO 97/31115 (1997-08-01), None
patent: WO 97/47358 (1997-12-01), None
patent: WO 97/48370 (1997-12-01), None
patent: WO 98/12207 (1998-03-01), None
patent: 98/12207 (1998-03-01), None
patent: WO 98/24922 (1998-06-01), None
Grantham et al., Nucleic Acid Research vol. 9, No. 1,(1981) r43-r74.
Peter Lind et al.. “Novel forms of B-domain-deleted recombinant factor VIII molecules Construction and biochemical characterization”,European Journal of Biochemistry, vol. 232, No. 1, pp. 19-27 (Aug. 15, 1995).
Carmel M. Lynch et al, “Sequences in the Coding Region of Clotting Factor VIII Act as Dominant Inhibitors of RNA Accumulation and Protein Production”,Human Gene Therapy, vol. 4, No. 3, pp. 259-272 (Jun. 1, 1993).
Louise C. Wasley et al., “PACE Furin Can Process the Vitamin K-dependent Pro-factor IX Precursor within the Secretory Pathway”,Journal of Biological Chemistry, vol. 268, No. 12, pp. 8458-8465 (Apr. 25, 1993).
Chiu et al., “Engineered GFP as a vital reporter in plants”,Current Biology, vol. 6, No. 3, pp 325-330 (1996).
D'Onofrio et al., “Correlations between the Compositional Properties of Human Genes, Codon Usage, and Amino Acid Composition of Proteins”,Journal of Molecular Evolution, vol. 32, No. 6, pp 504-510 (1991).
Eyre-Walker, “An Analysis of Codon Usage in Mammals: Selection or Mutation Bias?”,Journal of Molecular Evolution, vol. 33, No. 5, pp 442-449 (1991).
Haas et al., “Codon usage limitation in the expression of HIV-1 envelope glycoprotein”,Current Biology, vol. 6, No. 3, pp 315-324 (1996).
Hannig et al., “Strategies for optimizing heterologous protein expression inEscherichia coli”; TIBTECH, vol. 16, pp 54-60 (1998).
Herrick et al., “Identification and Comparison of Stable and Unstable MRNAs inSaccharomyces cerevisiae”, Molecular and Cellular Biology, vol. 10, No. 5, pp 2269-2284 (1990).
Herrick et al., “The Half-Life of c-mycmRNA in Growing and Serum-Stimulated Cells: Influence of the Coding and 3' Untranslated Regions and Role of Ribosome Translocation”,Molecular and Cellular Biology, vol. 14, No. 3, pp 2119-2128 (1994).
Hoekema et al., “Codon Replacement in thePGKIGene ofSaccharomyces cerevisiae: Experimental Approach To Study the Role of Biased Codon Usage in Gene Expression”,Molecular and Cellular Biology, vol. 7, No. 8, pp 2914-2924 (1987).
Hubatsch et al., “Human glutathione transferase A4-4: an Alpha class Enzyme with high catalytic efficiency in the conjunction of 4-hydroxynonenal and other genotoxic products of lipid peroxidation”;Biochem. J., 330, pp 175-179 (1998).
Kim et al., “Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells”;GENE, pp 293-301 (1997).
Kurland, “Codon bias and gene expression”,FEBS Letters, vol. 285, No. 2, pp 165-169 (1991).
Mehta et al., “Optimization Gene Synthesis, High Level Expression, Isotopic Enrichment, and Refolding of Human Interleukin-5”;Protein Expression and Purification, 11, pp 86-94 (1997).
Parker et al., “Translation and a 42-nucleotide segment within the coding region of the mRNA encoded by theMATα1gene are involved in promoting rapid mRNA decay in yeast”,Proc. Natl. Acad. Sci. vol. 87, No. 7, pp 2780-2784 (1990).
Solomovici et al., “DoesEscherichia coliOptimize the Economics of the Translation Process?”;J. theor. Biol., 185, pp 511-521 (1997).
Wright, “The ‘Effective number of codons’ used in a gene”,Gene, vol. 87, No. 1, pp 23-29 (1990).
Yang et al., “Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein”,Nucleic Acids Research, vol. 24, No. 22, pp 4592-4593 (1996).
Zhang et al., “An Enhanced Green Fluorescent Protein Allows Sensitive Detection of Gene Transfer in Mammalian Cells”,Biochemical and Biophysical Research Communications, vol. 227, No. 3, pp 707-711 (1996).
Zhang et al., “Graphic Analysis of Codon Usage Strategy in 1490 Human Proteins”,Journal of Protein Chemistry, vol. 12, No. 3, pp 329-335 (1993).
Andre et al., “Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage”;Journal of Virology, vol. 72, No. 2, pp 1497-1503 (1998).
Berg et al., “Growth Rate-optimized tRNA Abundance and Codon Usage”;J. Mol. Biol., pp 544-550 (1997).
Billinton, et al., “Development of a green fluorescent protein reporter for a yeast genotoxicity biosensor”;Biosensors&Bioelectronics13 pp 831-838 (1998).
Miller Allan M.
Selden Richard F
Treco Douglas A.
Kam Chih-Min
Transkaryotic Therapies Inc.
Weber Jon
LandOfFree
Optimized messenger RNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optimized messenger RNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optimized messenger RNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3474478